Arbutus Biopharma Corp

ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 561 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Arbutus Biopharma Corp, Reports and events
Filed	Form	What it is	Accession number
2018-11-2617:30 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001171843-18-008152
2018-11-0717:11 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001171843-18-007727
2018-11-0717:11 ET	10-Q	Quarterly reportPeriod 2018-09-30	0001628280-18-013909
2018-10-2208:35 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001171843-18-007089
2018-10-0908:45 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-18-006907
2018-08-2809:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-18-006281
2018-08-1308:30 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-18-006009
2018-08-1018:25 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-18-005962
2018-08-0320:39 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001171843-18-005711
2018-08-0317:56 ET	10-Q	Quarterly reportPeriod 2018-06-30	0001628280-18-010369
2018-06-0818:02 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001171843-18-004516
2018-05-2515:03 ET	8-K	5.07 Shareholder vote results	0001104659-18-035974
2018-05-0417:37 ET	10-Q	Quarterly reportPeriod 2018-03-31	0001628280-18-005886
2018-05-0317:28 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001171843-18-003482
2018-04-3011:53 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-18-003169
2018-04-2511:59 ET	DEF 14A	Proxy statementPeriod 2018-04-23	0001628280-18-004972
2018-04-1212:30 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-18-002667
2018-04-1208:01 ET	8-K	1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits	0001171843-18-002661
2018-03-2918:06 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-18-002346
2018-03-1608:44 ET	10-K	Annual reportPeriod 2017-12-31	0001628280-18-003276
2018-03-1416:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001171843-18-001950
2018-03-1209:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-18-001847
2018-02-2217:14 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-18-001364
2018-02-1521:10 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001171843-18-001157
2018-02-1414:40 ET	8-K	5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits	0001171843-18-001133
2018-02-0809:27 ET	8-K	2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001171843-18-000976
2018-01-1716:39 ET	8-K	5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits	0000912282-18-000013
2018-01-1609:01 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-18-010719
2018-01-1608:54 ET	SC 13D/A	Ownership report, active investor, amended	0001144204-18-002184
2018-01-1608:34 ET	SC 13D/A	Ownership report, active investor, amended	0000903423-18-000017
2018-01-1608:28 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-18-010679
2018-01-1607:31 ET	SC 13D/A	Ownership report, active investor, amended	0001104659-18-002227
2018-01-1606:08 ET	SC 13D/A	Ownership report, active investor, amended	0001104659-18-002185
2017-12-0614:54 ET	DEF 14A	Proxy statementPeriod 2017-12-06	0001628280-17-012143
2017-11-2709:00 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-17-007282
2017-11-1613:53 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-17-007093
2017-11-1417:59 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-17-006946
2017-11-0217:23 ET	10-Q	Quarterly reportPeriod 2017-09-30	0001628280-17-010727
2017-11-0216:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001171843-17-006559
2017-11-0119:09 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-17-006443
2017-10-2408:54 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-17-006223
2017-10-1809:53 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-17-006118
2017-10-1716:05 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-17-006099
2017-10-1709:23 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-17-311415
2017-10-1709:13 ET	SC 13D/A	Ownership report, active investor, amended	0001193125-17-311408
2017-10-1709:13 ET	SC 13D/A	Ownership report, active investor, amended	0001144204-17-052744
2017-10-1708:56 ET	SC 13D/A	Ownership report, active investor, amended	0000903423-17-000620
2017-10-1708:20 ET	SC 13D/A	Ownership report, active investor, amended	0001104659-17-062446
2017-10-1706:07 ET	SC 13D/A	Ownership report, active investor, amended	0001104659-17-062424
2017-10-1008:37 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001171843-17-005981

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.